Abstract
Our recent study of the mitotic checkpoint protein BUB1 (budding uninhibited by benzimidazoles 1) revealed several apparent BUB1 knock-out cell lines expressing low levels of BUB1 protein sufficient to support spindle assembly checkpoint activity. This rings alarm bells on the application of CRISPR technology.
Original language | English |
---|---|
Article number | 1603436 |
Journal | Molecular & Cellular Oncology |
Volume | 6 |
Issue number | 4 |
ISSN | 2372-3556 |
DOIs | |
Publication status | Published - 4 Jul 2019 |